Back

Coexistence of coronary microvascular dysfunction and left ventricular hypertrophy can predict prognosis of patients with nonobstructive coronary arteries.

31 August 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: Detection of microvascular dysfunction (2) Coronary Microcirculation and Collaterals ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Aki Ito

Yokosuka Kyosai Hospital, Yokosuka (Japan)

5 More presentations in this session

Presentation thumbnail
Predictive factors and gender insights into abnormal myocardial flow reserve in non-obstructive coronary artery disease: a CZT-SPECT analysis
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Coronary physiology: no complete diagnosis without acteylcholine
Doctor D. O h-Ici (Galway, IE)
Abstract Slides Video
Presentation thumbnail
The influence of epicardial resistance on Microvascular Resistance Reserve (MRR)
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
The relationship between coronary microvascular dysfunction and left ventricular longitudinal systolic function in patients with diabetes mellitus
Professor Y. Wang (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Temporal changes in FFR in initially deferred vessels in symptomatic patients
Mr R. Shuja (Russellville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Detection of microvascular dysfunction (2)

The Event

Event poster

ESC Congress 2024

31 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic stratification by coronary flow reserve and left atrial volume index in patients with non-obstructive coronary artery disease
thumbnail
Congress Presentation
Synergic interaction between coronary flow reserve and left atrial diameter as a risk factor for major adverse cardiovascular events in patients with nonobstructive coronary artery disease.
thumbnail
Congress Presentation
Coronary microvascular dysfunction endotypes and clinical outcomes in patients with ischemia and no obstructive coronary arteries: A meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources